Covered recipient · General Payments record
AHMAD B AL-HAMDA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology
General Payments · PY2018–2024
$8,801.64
- Reported across 506 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.65 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $79.91 | 3 |
| Amneal Pharmaceuticals LLC | $40.23 | 2 |
| ABBVIE INC. | $31.39 | 2 |
| Biogen, Inc. | $29.90 | 1 |
| Alexion Pharmaceuticals, Inc. | $26.68 | 1 |
| Lilly USA, LLC | $21.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.84 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194552 | CMS |
| ABBVIE INC. | $14.55 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194554 | CMS |
| Alexion Pharmaceuticals, Inc. | $26.68 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093934312 | CMS |
| Amneal Pharmaceuticals LLC | $23.47 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178405 | CMS |
| Amneal Pharmaceuticals LLC | $16.76 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178407 | CMS |
| Biogen, Inc. | $29.90 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104818888 | CMS |
| Lilly USA, LLC | $21.54 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136005373 | CMS |
| SK Life Science, Inc. | $24.07 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150223 | CMS |
| SK Life Science, Inc. | $28.41 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150291 | CMS |
| SK Life Science, Inc. | $27.43 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150331 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.